Neuropediatrics 2004; 35(3): 174-182
DOI: 10.1055/s-2004-820994
Original Article

Georg Thieme Verlag KG Stuttgart · New York

Long-Term Observations of Patients with Infantile Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1)

S. Rudnik-Schöneborn1 , P. Stolz2 , R. Varon3 , K. Grohmann2 , 4 , M. Schächtele5 , U.-P. Ketelsen6 , D. Stavrou7 , H. Kurz8 , C. Hübner2 , K. Zerres1
  • 1Institute for Human Genetics, Aachen University of Technology, Aachen, Germany
  • 2Department of Neuropaediatrics, Charité, University Hospital Berlin, Berlin, Germany
  • 3Institute of Human Genetics, Charité, University Hospital Berlin, Berlin, Germany
  • 4Institute for Clinical Neurobiology, University of Würzburg, Würzburg, Germany
  • 5Children's Hospital Karlsruhe, Karlsruhe, Germany
  • 6Department of Neuropaediatrics and Muscular Diseases, University of Freiburg, Freiburg, Germany
  • 7Institute for Neuropathology, Neurocenter, University of Hamburg, Hamburg, Germany
  • 8Department of Paediatrics, SMZ Ost Donauspital, Vienna, Austria
Further Information

Publication History

Received: August 30, 2003

Accepted after Revision: April 8, 2004

Publication Date:
12 July 2004 (online)

Abstract

We describe 6 unrelated patients affected by infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) with prolonged survival upon mechanical ventilation (4.5 - 11 years), which has not been reported before. Biallelic mutations in the IGHMBP2 gene proved the diagnosis of SMARD1 in all patients. Disease onset was in the first 2 months in the described patients, starting with generalised hypotonia, failure to thrive, and early breathing difficulties. Diaphragmatic palsy was diagnosed and permanent ventilation was initiated 2 - 8 months after onset. Within months a more distal muscular atrophy became evident associated with joint contractures (talipes), hand drops, and fatty finger pads. Motor development remained minimal, loss of function was observed within the first year after which no further progression was recorded. Voiding dysfunction with reflux nephropathy was observed in 3 patients and has not been reported before. Further evidence of autonomic nerve dysfunction resulting in cardiac arrhythmia, hypertension, and excessive sweating was given in 2 patients. Investigative results were largely compatible with those obtained in classic SMA. However, neurogenic atrophy muscle was more pronounced in distal muscles, if examined, and there was evidence of peripheral nerve involvement at least in some patients.

References

  • 1 Bach J R, Baird J S, Plosky D, Navado J, Weaver B. Spinal muscular atrophy type 1: management and outcomes.  Pediatr Pulmonol. 2002;  34 16-22
  • 2 Bertini E, Gadisseux J L, Palmieri G, Ricci E, Di Capua M, Ferriere G. et al . Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.  Am J Med Genet. 1989;  33 328-335
  • 3 Bove K E, Iannaccone S T. Atypical infantile spinomuscular atrophy presenting as acute diaphragmatic paralysis.  Pediatr Pathol. 1988;  8 95-107
  • 4 Cox G A, Mahaffey C L, Frankel W N. Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele.  Neuron. 1998;  21 1327-1337
  • 5 Eckstein H B. The investigation of the neuropathic bladder. Brodehl J, Ehrich JHH Paediatric Nephrology. Berlin; Springer 1984: chapter 2.16
  • 6 Grohmann K, Wienker T F, Saar K, Rudnik-Schöneborn S, Stoltenburg-Didinger G, Rossi R. et al . Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form is linked to chromosome 11q13-q21.  Am J Hum Genet. 1999;  65 1459-1462
  • 7 Grohmann K, Schuelke M, Diers A, Hoffmann K, Lucke B, Adams C. et al . Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.  Nat Genet. 2001;  29 75-77
  • 8 Grohmann K, Varon R, Stolz P, Schuelke M, Janetzki C, Bertini E. et al . Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).  Ann Neurol. 2003;  54 719-724
  • 9 McWilliam R C, Gardner-Medwin D, Doyle D, Stephenson J BP. Diaphragmatic paralysis due to spinal muscular atrophy.  Arch Dis Child. 1985;  60 145-149
  • 10 Molnar G M, Crozat A, Kraeft S K, Dou Q P, Chen L B, Pardee A B. Association of the mammalian helicase MAH with the pre-mRNA splicing complex.  Proc Natl Acad Sci USA. 1997;  94 7831-7836
  • 11 Novelli G, Capon F, Tamisari L, Grandi E, Angelini C, Guerrini P. et al . Neonatal spinal muscular atrophy with diaphragmatic paralysis is unlinked to 5 q11. 2-q13.  J Med Genet. 1995;  32 2161-2219
  • 12 Pitt M, Houlden H, Jacobs J, Mok Q, Harding B, Reilly M. et al . Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1.  Brain. 2003;  126 1-11
  • 13 Rudnik-Schöneborn S, Forkert R, Hahnen E, Wirth B, Zerres K. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings.  Neuropediatrics. 1996;  27 8-15
  • 14 Rudnik-Schöneborn S, Goebel H H, Schlote W, Molaian S, Omran H, Ketelsen U-P. et al . Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy.  Neurology. 2003;  60 983-987
  • 15 Stoltenburg-Didinger G, Diers A, Kaczinski M, Grohmann K, Varon-Mateeva R, Hübner C. Ultrastructure of peripheral nerves and the neuromuscular junction in spinal muscular atrophy with respiratory distress type 1.  Brain Pathol. 2003;  13 S40

PD Dr. Sabine Rudnik-Schöneborn

Institute for Human Genetics
Aachen University of Technology

Pauwelsstraße 30

52074 Aachen

Germany

Email: srudnik-schoeneborn@ukaachen.de

    >